Daymark Wealth Partners’s HCA Healthcare HCA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.37M | Sell |
3,579
-124
| -3% | -$47.5K | 0.05% | 223 |
|
|
2025
Q1 | $1.28M | Buy |
3,703
+890
| +32% | +$308K | 0.06% | 211 |
|
|
2024
Q4 | $844K | Buy |
2,813
+230
| +9% | +$69K | 0.04% | 258 |
|
|
2024
Q3 | $1.05M | Buy |
2,583
+279
| +12% | +$113K | 0.04% | 239 |
|
|
2024
Q2 | $740K | Sell |
2,304
-657
| -22% | -$211K | 0.03% | 277 |
|
|
2024
Q1 | $988K | Sell |
2,961
-37
| -1% | -$12.3K | 0.05% | 198 |
|
|
2023
Q4 | $811K | Buy |
2,998
+243
| +9% | +$65.8K | 0.05% | 207 |
|
|
2023
Q3 | $678K | Buy |
2,755
+157
| +6% | +$38.6K | 0.05% | 208 |
|
|
2023
Q2 | $788K | Sell |
2,598
-430
| -14% | -$130K | 0.06% | 186 |
|
|
2023
Q1 | $798K | Buy |
3,028
+88
| +3% | +$23.2K | 0.11% | 151 |
|
|
2022
Q4 | $705K | Buy |
+2,940
| New | +$705K | 0.12% | 122 |
|